No doubt about it, UTIs suck.

They burn, they itch, they come back just when you think youre in the clear.

But for those dealing with these relentless infections, theres finally a new line of defense.

E. Coli bacteria (in red) being grown on an agar plate. These bacteria are a common source of UTIs.

E. Coli bacteria (in red) being grown on an agar plate. These bacteria are a common source of UTIs.© Scharvik via Getty

A new key in of antibiotic is now available for some of the most annoying infections around.

UTIsare some of the most common infections that people encounter, particularly women.

So scientists have been desperate to find newer antibiotics that can treat these resistant infections.

Mrsa

Orlynvah is the first drug of its kind.

The drug has been approved to treat certain uncomplicated UTIs caused byEscherichia coli, Klebsiella pneumoniae, or Proteusmirabilisbacteria.

The drug failed to pass clinical trials testing its effectiveness against complicated UTIs or complicated intra-abdominal infections.

Journavx Bottle

Still, Orlynvah should be able to prevent plenty of UTI-related misery.

News from the future, delivered to your present.

Shigella

Cobenfy

MRSA

Drug Pills

Jblflip6

Eufysolocam

Alicia Witt in Urban Legend

Hp14

U.S. President Donald Trump speaks to the media during a guided tour of the John F. Kennedy Center for the Performing Arts before leading a board meeting on March 17, 2025 in Washington, DC.

Metaquest3s

Sharks

Animaid The Art Of Animation

Jblflip6

Eufysolocam

Alicia Witt in Urban Legend

Hp14

An image of a small disposable vape with a green case and mouth piece and visible oil in a clear container.

An image of a hand holding a black vape with a vibrant blue chamber where you can faintly see a laser.

Framework 13 Laptop 1 Hero

Samsung Odyssey 3d 6